title: Successful mobilization of peripheral blood stem cells in an acute promyelocytic leukemia patient after gemtuzumab ozogamicin.
authors.forename: T
authors.initials: T
authors.lastname: Muta
authors.forename: K
authors.initials: K
authors.lastname: Kato
authors.forename: S
authors.initials: S
authors.lastname: Oku
authors.forename: R
authors.initials: R
authors.lastname: Nawata
authors.forename: K
authors.initials: K
authors.lastname: Takase
authors.forename: H
authors.initials: H
authors.lastname: Henzan
authors.forename: F
authors.initials: F
authors.lastname: Arima
authors.forename: T
authors.initials: T
authors.lastname: Eto
mesh_terms: D000617:Aminoglycosides / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D005260:Female; D000079982:Gemtuzumab; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000628:therapy*; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D012074:Remission Induction; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000079982:Gemtuzumab